Comparison · Pregnancy Smart
EPDS vs PHQ-9 Depression Screening
How do the options compare?
The lens is a clinician's: guideline endorsement, pregnancy evidence, dosing, onset, and tolerability. Cost and formulation notes appear where relevant.
| Option | Studied pregnancy dose | Guideline support | Notes |
|---|---|---|---|
| EPDS (Edinburgh Postnatal Depression Scale) | 10 items; developed in 1987 specifically for primary care detection of postpartum depression | A factor-structure study recommends EPDS as the preferred tool across the perinatal period, both pregnancy and postpartum | Median sensitivity around 81 to 82% and specificity around 73 to 75% in pooled comparisons, though individual studies vary; scores are not directly comparable between pregnancy and postpartum |
| PHQ-9 (Patient Health Questionnaire-9) | 9 items; a general depression screening tool adapted for perinatal use rather than built specifically for pregnancy or postpartum | Performs comparably to EPDS in most pooled analyses, but one factor-structure study found its structure fits poorly after birth | Pooled sensitivity 0.84 and specificity 0.81 in a meta-analysis of 7 criterion validity studies |
- A meta-analysis pooling multiple criterion validity studies found PHQ-9 at its standard cutoff of 10 or higher had a pooled sensitivity of 0.84 and specificity of 0.81 for perinatal depression, and separately found the median sensitivity, specificity, and area under the curve of PHQ-9 and EPDS were remarkably similar across 5 head-to-head studies, at roughly 0.81 versus 0.82 sensitivity and 0.75 versus 0.73 specificity. 1
- In one study directly comparing three postpartum screening instruments by phone at 6 to 8 weeks, EPDS at a cutoff of 10 or higher identified 62% of depression cases with 88% specificity, while PHQ-9 at the same cutoff identified only 31% of cases, and EPDS's overall accuracy, an area under the curve of 0.75 versus 0.59 for PHQ-9, was reported as significantly higher in that particular sample. 2
- A confirmatory factor analysis testing both instruments across the antepartum and postpartum periods found PHQ-9 showed adequate performance only in the antenatal group, with inconsistent factor loadings and a poor model fit in the postpartum group, leading the authors to conclude EPDS should be preferred over PHQ-9 for measuring depressive symptoms across the perinatal population, while cautioning that even EPDS scores are not directly comparable between the antepartum and postpartum periods. 3
- EPDS was developed in 1987 specifically to help primary care clinicians detect postpartum depression, and it has since become one of the most widely used screening questionnaires for depression symptoms across pregnancy and the period after birth. 4
Which option makes sense?
The comparison above is intentionally evidence-first, not brand-first. Please consult your healthcare provider to translate it into a plan that fits your pregnancy specifics.
Disclosure: Pregnancy Smart is a supplement maker. The options compared above sit outside our own product line; this page describes their pregnancy evidence on its own merits.
Frequently asked questions
Why do different providers use different depression screening questionnaires?
Both EPDS and PHQ-9 are validated options, and which one a practice uses often comes down to what is built into their electronic health record or clinical workflow rather than one being chosen over the other for accuracy reasons.
Does it matter which screening tool I take?
For catching a likely depression concern, most head-to-head research finds the two tools perform similarly. One study looking specifically at the underlying structure of each tool found PHQ-9 fits the data less well after birth than EPDS does, which is a reason some researchers now prefer EPDS for the full perinatal period.
Is EPDS more accurate than PHQ-9?
Results vary by study. A large pooled meta-analysis found the two nearly identical in sensitivity and specificity, while one smaller postpartum-specific study found EPDS notably more accurate at the cutoffs it used. Neither result should be read as the final word on its own.
Why would PHQ-9 work less well after birth than during pregnancy?
A factor-analysis study found PHQ-9's items held together statistically well during pregnancy but showed inconsistent patterns and a poor overall fit in the postpartum group, suggesting some of its items may capture the postpartum experience less cleanly than EPDS's items do.
Can I ask my provider for a specific screening questionnaire?
You can ask, and a provider can typically administer either one, since both are validated and in common clinical use. There is no strong evidence-based reason to insist on one over the other for an individual screening visit.
Do EPDS and PHQ-9 use the same cutoff score to flag concern?
No, they use different scoring scales and different studies have tested different cutoff points for each, so a score on one is not directly interchangeable with a score on the other. Your provider interprets whichever tool was used against its own established thresholds.
Is EPDS only used after birth, or also during pregnancy?
Despite the word 'postnatal' in its name, EPDS is commonly used during pregnancy as well as postpartum, and research recommending it as the preferred tool considered its performance across both periods.
What happens after a positive screen on either tool?
A positive screen on EPDS or PHQ-9 is a starting point for a further conversation with your provider, not an assessment on its own, and typically leads to a fuller clinical discussion, a referral, or follow-up screening depending on your specific score and symptoms.
Related in the library
References
PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC9112666/
Screening for Depression in the Postpartum Period: A Comparison of Three Instruments
PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC7083208/
PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC10491522/
Screening of Perinatal Depression Using the Edinburgh Postpartum Depression Scale
PMC · https://pmc.ncbi.nlm.nih.gov/articles/PMC9948039/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
